These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31485)

  • 21. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
    Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
    Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and irreversible beta-adrenergic blockade with a bromoacetamido derivative of betaxolol.
    Amlaiky N; Leclerc G
    J Pharm Sci; 1985 Oct; 74(10):1117-9. PubMed ID: 2867200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases.
    Manoury PM; Binet JL; Rousseau J; Lefèvre-Borg F; Cavero IG
    J Med Chem; 1987 Jun; 30(6):1003-11. PubMed ID: 2884312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ether derivatives of 3-amino-1,2-propanediol, II: synthesis and pharmacological investigation of n-substituted derivatives of 1-cycloalkyloxy-3-amino-2-propanols (author's transl)].
    Dantschev D; Georgiev A; Tschalina E; Dobreva-Usunova D; Staneva D
    Arch Pharm (Weinheim); 1979 Oct; 312(10):857-63. PubMed ID: 44460
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols.
    Tucker H
    J Med Chem; 1980 Oct; 23(10):1122-6. PubMed ID: 6106716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols.
    Gombar V
    Arzneimittelforschung; 1986 Jul; 36(7):1014-8. PubMed ID: 2876713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and beta-adrenergic antagonism of 2-(aryloxy)-1-(2-piperidyl)ethanols.
    Mauleón D; Pujol MD; Rosell G
    J Med Chem; 1988 Nov; 31(11):2122-6. PubMed ID: 2903245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
    Gibson JK; Gelband H; Bassett AL
    J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
    Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
    J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and adrenergic beta-blocking activity of some 1,3-benzodioxole derivatives.
    Tatsuno H; Goto K; Shigenobu K; Kasuya Y; Obase H
    J Med Chem; 1977 Mar; 20(3):394-7. PubMed ID: 15112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and beta-adrenergic blocking effects of timolol.
    Mouillé P; Schmitt H; Cheymol G; Gauter E
    Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
    Lee RJ; Evans DB; Baky SH; Laffan RJ
    Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 36. Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent.
    Erhardt PW; Woo CM; Gorczynski RJ; Anderson WG
    J Med Chem; 1982 Dec; 25(12):1402-7. PubMed ID: 6130153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A structure activity relationship study on 1-isopropylamino-3-(2'-substituted naphthoxy)-propan-2-ois analogs.
    Srivastava AK; Mishra N; Khan AA; Gupta DK
    Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):351-4. PubMed ID: 7827810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
    Erhardt PW; Woo CM; Anderson WG; Gorczynski RJ
    J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-adrenergic blocking agents. 24. Heterocyclic substituted 1-(aryloxy)-3-[[(amido)alkyl]amino]propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1982 Dec; 25(12):1417-22. PubMed ID: 6130155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-adrenoceptor studies. 2. Effects of alkyl substitution on beta-adrenoceptor blocking, antiarrhythmic, and local anesthetic activities of 1,1'-(o-phenylenedioxy)bis(3-isopropylamino-2-propanol).
    Zaagsma J; Nauta WT
    J Med Chem; 1977 Apr; 20(4):527-31. PubMed ID: 15113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.